Lon Schneider

Trials

Studies that name Lon Schneider as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:45 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT05267535 · Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

  Neurim Pharmaceuticals Ltd. · terminated · Alzheimer's Disease · study chair
• Ph2
  NCT04838301 · Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

  University of Arizona · active not recruiting · Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases · principal investigator
• Ph2
  NCT02615002 · Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

  Neurim Pharmaceuticals Ltd. · completed · Alzheimer's Disease · study chair
• Ph3
  NCT00898807 · Citalopram for Agitation in Alzheimer's Disease

  JHSPH Center for Clinical Trials · completed · Alzheimer's Disease, Agitation · principal investigator
• N/A
  NCT00015548 · CATIE-Alzheimer's Disease Trial

  National Institute of Mental Health (NIMH) · completed · Alzheimer's Disease · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 06:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Clinical Core
  P30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2020 to 2026 · $1,242,021 awarded in 2026
  Same name and institution; not confirmed by an ID
• Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
  R01AG063826 · NIA · UNIVERSITY OF ARIZONA · fiscal years 2019 to 2025 · $6,580,973 awarded in 2025
  Grant number is on one of their registry trials
• (-)-Phenserine inhibition of neuronal death in Alzheimer’s disease and developing brain-labeled plasma exosomes assays as biomarkers for a phenserine phase 1b ascending dose trial
  R01AG062687 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2019 to 2023 · $714,437 awarded in 2023
  Same name and institution; not confirmed by an ID
• Clinical Core
  P50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 1996 to 2019 · $732,587 awarded in 2019
  Same name and institution; not confirmed by an ID
• Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase I
  UF1AG046148 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2013 · $2,429,633 awarded in 2013
  Same name and institution; not confirmed by an ID
• Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve
  R01AG037561 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2011 to 2013 · $507,887 awarded in 2013
  Same name and institution; not confirmed by an ID
• Estrogen Receptor-beta phytoSERMs for Management of Menopause and Memory Decline
  R01AG033288 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2010 to 2012 · $414,297 awarded in 2012
  Same name and institution; not confirmed by an ID
• Depression in Alzheimer's Disease Study 2 (DIADS-2)
  U01MH066175 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2003 to 2007 · $115,916 awarded in 2007
  Same name and institution; not confirmed by an ID
• CARBAMAZEPINE TRIAL IN AGITATED ALZHEIMERS OUTPATIENTS
  R01MH048759 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 1992 to 1995 · $56,952 awarded in 1995
  Same name and institution; not confirmed by an ID
• FACULTY SCHOLAR AWARD IN GERIATRIC MENTAL HEALTH
  T01MH019074 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 1988 to 1991 · $118,474 awarded in 1991
  Same name and institution; not confirmed by an ID
• GERIATRIC PSYCHIATRIC FELLOWSHIP PROGRAM
  T01MH019213 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 1990 to 1991 · $36,180 awarded in 1991
  Same name and institution; not confirmed by an ID
• NIMH CLINICAL TRAINING
  T01MH017392 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 1986 to 1988 · $56,160 awarded in 1988
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Citalopram Treatment for Agitation in Alzheimer Dementia
  R01AG031348 · NIA · JOHNS HOPKINS UNIVERSITY · PI CONSTANTINE G LYKETSOS · fiscal years 2008 to 2012
  Named on NCT00898807
• CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES-278990001
  N01MH090001 · NIMH · UNIVERSITY OF NORTH CAROLINA C · PI · fiscal years 1989 to 2003
  Named on NCT00015548